Renal venous thrombosis in a neonate carrying the g20210a mutation of the prothrombin gene [3];Trombosis venosa renal en recién nacida portadora de la mutación G20210A del gen de la protrombina

Anales de Pediatria

Volumn 62, Issue 5, 2005, Pages 480-482

  Fraga Rodriguez G Ma ^a   Parody Porras, R ^a   Ginovart Galiana, G ^a   Montserrat Esplugas, E ^a   Badell Serra, I ^a   Fontcuberta Boj, J ^a   Cubells Riero J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEMIPARIN; GUANINE; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN;

CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; GENE MUTATION; HEPARINIZATION; HUMAN; KIDNEY VEIN THROMBOSIS; LABORATORY TEST; LASER DOPPLER FLOWMETRY; LETTER; NEWBORN; NEWBORN DISEASE; THROMBOPHILIA;

EID: 20444468392     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074626     Document Type: Letter

References (10)

1. Kosch A, Kuwertz-Bröking E, Heller Ch, Kurnik K, Schoebess R, Nowak-Göttl U. Renal venous thrombosis in neonates: Prothrombotic risk factors and long-term follow-up. Blood. 2004;104:1356-60.
2. Chan AK, Deveber G, Monagle P, Brookers LA, Massicottes PM. Venous thrombosis in children. J Thromb Haemost. 2003; 1:1443-55.
3. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variant in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and a increased in venous thrombosis. Blood. 1996;88: 3698-703.
4. Souto JC, Coll I, Llobet D, Del Río E, Oliver A, Mateo J, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolismin the Spanish population. Thromb Haemost. 1998;80:366-9.
5. Souto JC, Mateo J, Soria JM, Llobet D, Coll I, Borrell M, et al. Homozigotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboemboiism. Haematologica. 1999;84:627-32.
6. Kuhle S, Massicotte P, Chan A, Mitchell L. A case series of 72 neonates with renal vein thrombosis. Thromb Haemost. 2004;92:929-33.
7. Chalmers EA, Gibson BES. Thrombolytic therapy in the management of paediatric thromboembolic disease. Brit J Haematol. 1999;104:14-21.
8. Kuhle S, Massicotte P, Andrew M, Dinyari M, Marzinotto V, Mitchell D, et al. A dose finding study of tinzaparin in pediatric patients [abstract]. Blood. 2002;100:279.
9. Farnoux C, Camard O. Pinquier D, Hurtaud-Roux MF, Sebag G, Schlegel N, et al. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates. J Pediatr. 1998; 133:137-40.
10. Zenz W, Arlt F, Sodia S, Berghold A. Intracerebral hemorrhage during fibrinolytic therapy in children: A review of the literature of the last thirty years. Sem Thromb Hemost. 1997;23: 321-32.